Micko22 - the cost of treatment to the pt is generally a far cry form the sales revenue of OSL, or any medical device maker.
The May20 prese estimating $25k per device is IMO the cost to the pt, not the amount OSL would receive. Happy to be corrected is there is any solid data showing that.
Of course if that were OSL revenue then that would suggest only 3 sales in 6 months. Therefore I suggest this is not the amount OSL sales the product for.
- Forums
- ASX - By Stock
- Ann: First Austria-based treatments utilising the OncoSil device
Micko22 - the cost of treatment to the pt is generally a far cry...
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OSL (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.4¢ |
Change
-0.001(20.0%) |
Mkt cap ! $12.02M |
Open | High | Low | Value | Volume |
0.4¢ | 0.5¢ | 0.4¢ | $18.20K | 3.850M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
33 | 21860266 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 29058628 | 14 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
33 | 21860266 | 0.004 |
15 | 14636597 | 0.003 |
5 | 3757526 | 0.002 |
4 | 7600000 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 29058628 | 14 |
0.006 | 13512735 | 16 |
0.007 | 21920981 | 19 |
0.008 | 2247500 | 6 |
0.009 | 1417500 | 3 |
Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
Last
0.5¢ |
  |
Change
-0.001 ( 11.1 %) |
|||
Open | High | Low | Volume | ||
0.5¢ | 0.5¢ | 0.5¢ | 1975000 | ||
Last updated 14.06pm 06/05/2024 ? |
Featured News
OSL (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
Previous Video
Next Video
SPONSORED BY The Market Online